GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Mannkind Corporation (MNKD) [hlAlert]

Rating:
Underweight
MNKD
down 80.30 %

Mannkind Corporation (MNKD) downgraded to Underweight with price target $0.05 by Piper Jaffray

Posted on: Wednesday,  Jan 6, 2016  10:25 AM ET by Piper Jaffray

Piper Jaffray rated Underweight Mannkind Corporation (NASDAQ: MNKD) on 01/06/2016, when the stock price was $0.77. Since
then, Mannkind Corporation has gained 407.79% as of 01/06/2016's recent price of $3.91.
If you would have followed this Piper Jaffray's recommendation on MNKD, you would have lost 80.3% of your investment in 0 days.

Mannkind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Company's lead product, the Technosphere Insulin System, consists of the Company's dry-powder Technosphere formulation of insulin and the Company's MedTone inhaler through which the powder is inhaled into the deep lung.

At Piper Jaffray, we understand there’s no substitute for relevant and timely research. That's why we provide: * fundamental and technical research * value-added investment ideas * market analysis With the information our research team provides, you’ll make better and more informed decisions for your portfolio.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/6/2016 10:25 AM Sell
None
0.77 0.05
as of 10/17/2014
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/27/2013 8:25 AM Hold
None
5.02
4/10/2008 8:25 AM Hold
None
2.34

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy